CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 106 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,208 | -99.9% | 360 | -99.9% | 0.00% | -100.0% |
| Q2 2023 | $3,431,501 | -38.4% | 255,320 | -24.0% | 0.32% | -34.0% |
| Q1 2023 | $5,569,222 | -16.8% | 335,900 | -6.6% | 0.48% | -15.7% |
| Q4 2022 | $6,692,280 | +8.3% | 359,800 | -25.3% | 0.57% | +1.3% |
| Q3 2022 | $6,180,000 | +34.5% | 481,700 | -26.5% | 0.56% | +51.9% |
| Q2 2022 | $4,595,000 | -14.7% | 655,600 | +0.9% | 0.37% | +5.7% |
| Q1 2022 | $5,388,000 | +8063.6% | 649,900 | +3722.9% | 0.35% | +3063.6% |
| Q4 2017 | $66,000 | – | 17,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |